| The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms JD Khoury, E Solary, O Abla, Y Akkari, R Alaggio, JF Apperley, R Bejar, ... leukemia 36 (7), 1703-1719, 2022 | 2858 | 2022 |
| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 2618 | 2022 |
| Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype N Jain, AV Lamb, S O’Brien, F Ravandi, M Konopleva, E Jabbour, Z Zuo, ... Blood, The Journal of the American Society of Hematology 127 (15), 1863-1869, 2016 | 363 | 2016 |
| Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study E Jabbour, H Kantarjian, F Ravandi, D Thomas, X Huang, S Faderl, ... The lancet oncology 16 (15), 1547-1555, 2015 | 319 | 2015 |
| Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy MG Serrano, HI Parikh, JP Brooks, DJ Edwards, TJ Arodz, L Edupuganti, ... Nature medicine 25 (6), 1001-1011, 2019 | 302 | 2019 |
| Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single … E Jabbour, NJ Short, F Ravandi, X Huang, N Daver, CD DiNardo, ... The Lancet Haematology 5 (12), e618-e627, 2018 | 262 | 2018 |
| Ewing sarcoma family of tumors JD Khoury Advances in anatomic pathology 12 (4), 212-220, 2005 | 243 | 2005 |
| Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase … H Kantarjian, F Ravandi, NJ Short, X Huang, N Jain, K Sasaki, N Daver, ... The Lancet Oncology 19 (2), 240-248, 2018 | 240 | 2018 |
| Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai–Dorfman disease S Garces, LJ Medeiros, KP Patel, S Li, S Pina-Oviedo, J Li, JC Garces, ... Modern Pathology 30 (10), 1367-1377, 2017 | 234 | 2017 |
| Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq JD Khoury, NM Tannir, MD Williams, Y Chen, H Yao, J Zhang, ... Journal of virology 87 (16), 8916-8926, 2013 | 230 | 2013 |
| Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy W Wang, JE Cortes, G Tang, JD Khoury, S Wang, CE Bueso-Ramos, ... Blood, The Journal of the American Society of Hematology 127 (22), 2742-2750, 2016 | 224 | 2016 |
| A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories M Herling, JD Khoury, LBT Washington, M Duvic, MJ Keating, D Jones Blood 104 (2), 328-335, 2004 | 208 | 2004 |
| BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells B Sun, W Fiskus, Y Qian, K Rajapakshe, K Raina, KG Coleman, AP Crew, ... Leukemia 32 (2), 343-352, 2018 | 184 | 2018 |
| Diffuse large B-cell lymphoma variants: an update N Sukswai, K Lyapichev, JD Khoury, LJ Medeiros Pathology 52 (1), 53-67, 2020 | 179 | 2020 |
| Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial E Jabbour, NJ Short, N Jain, X Huang, G Montalban-Bravo, P Banerjee, ... The Lancet Haematology 10 (1), e24-e34, 2023 | 162 | 2023 |
| Differential Expression and Clinical Significance of Tyrosine-phosphorylated STAT3 in ALK+ and ALK− Anaplastic Large Cell Lymphoma JD Khoury, LJ Medeiros, GZ Rassidakis, MA Yared, P Tsioli, V Leventaki, ... Clinical cancer research 9 (10), 3692-3699, 2003 | 154 | 2003 |
| CD56+ TdT+ blastic natural killer cell tumor of the skin: A primitive systemic malignancy related to myelomonocytic leukemia JD Khoury, LJ Medeiros, JT Manning, LE Sulak, C Bueso‐Ramos, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2002 | 143 | 2002 |
| TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow K Alayed, KP Patel, S Konoplev, RR Singh, MJ Routbort, N Reddy, ... American journal of hematology 88 (12), 1055-1061, 2013 | 140 | 2013 |
| Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray NA Abrahams, GT MacLennan, JD Khoury, AH Ormsby, P Tamboli, ... Histopathology 45 (6), 593-602, 2004 | 133 | 2004 |
| MYC/BCL6 double‐hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis S Li, P Desai, P Lin, CC Yin, G Tang, XJ Wang, SN Konoplev, JD Khoury, ... Histopathology 68 (7), 1090-1098, 2016 | 130 | 2016 |